default author photo

Luther A. Bartelt

University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases

SCHOLARLY PAPERS

2

DOWNLOADS

131

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Safety and Tolerability of Misoprostol in Adults with Clostridioides Difficile Infection – the Proclaim Trial

Number of pages: 12 Posted: 01 Nov 2023
David M. Aronoff, Robert R. Lavieri, Erik R. Dubberke, Sarah K. McGill, Luther A. Bartelt, Stephanie A. Smith, Balint K. Pandur, Sharon Phillips, Krista Vermillion, Jana Shirey-Rice, Jill Pulley, Yaomin Xu, Christopher J. Lindsell, Nicole Zaleski and Ryan S. Doster
Indiana University Purdue University Indianapolis (IUPUI) - Indiana University School of Medicine, Vanderbilt University, Washington University in St-Louis, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, Vanderbilt University, Vanderbilt University, Vanderbilt University - Department of Biostatistics, Vanderbilt University, Vanderbilt University, Vanderbilt University - Department of Medicine, Vanderbilt University Medical Center - Department of Biostatistics, Vanderbilt University, Vanderbilt University and University of Louisville
Downloads 68 (891,180)

Abstract:

Loading...

Misoprostol, Clostridioides difficile, diarrhea, Prostaglandins, Phewas

2.

Outcomes of Convalescent Plasma with Defined High- Versus Lower-Neutralizing Antibody Titers Against SARS-CoV-2 Among Hospitalized Patients: Coronavirus Inactivating Plasma (CoVIP), Double-Blind Phase 2 Study

Number of pages: 32 Posted: 25 Apr 2022
Luther A. Bartelt, Alena J. Markmann, Bridget Nelson, Jessica Keys, Heather Root, Heather I. Henderson, JoAnn Kuruc, Caroline Baker, D. Ryan Bhowmik, Yixuan Hou, Lakshmanane Premkumar, Caleb Cornaby, John Schmitz, Susan Weiss, Yara Park, Ralph S. Baric, Aravinda M. deSilva, Anne Lachiewicz, Sonia Napravnik, David van Duin and David M. Margolis
University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - UNC HIV Cure Center, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina School of Medicine - Department of Microbiology and Immunology, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology, University of North Carolina School of Medicine - Department of Microbiology and Immunology, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases, University of North Carolina (UNC) at Chapel Hill - Institute for Global Health and Infectious Diseases and The University of North Carolina at Chapel Hill - UNC HIV Cure Center
Downloads 63 (933,592)

Abstract:

Loading...

Antibodies, SARS-CoV-2, Convalescent Plasma, Immunology, neutralizing antibodies